Skip to content

Evaluation of drugs prescribed by physicians and their adherence to guidelines used in treatment of cancer related neuropathic pain.

Evaluation of the prescription pattern of drugs and adherence of physicians to NeuPSIG guidelines in treatment of cancer related neuropathic pain.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/03/008062
Enrollment
600
Registered
2017-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cancer patients experiencing Neuropathic Pain

Interventions

None listed

Sponsors

Dr Vishal Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender and age above of 18 years and below 80 years experiencing from neuropathic pain due to any cancer. 2. Patients diagnosed by treating physicians as having neuropathic pain using the screening tool DN4 Neuropathic pain diagnostic questionnaire with score >= 4 3. Patients willing to give voluntary informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with established diagnosis of neurogenic pain associated with localized peripheral neuropathies (e.g. Post herpetic neuralgia, Diabetic neuropathy, Post- surgical/traumatic neuropathic pain.) 2. Patients unable to comprehend the patient information sheet. 3. Patients diagnosed with fibromyalgia. 4. Any other medical condition, which in the opinion of the investigator precludes the inclusion of the participant.

Design outcomes

Primary

MeasureTime frame
Medications prescribed â?? details â??generic /brand, dose, dosage, frequency and duration, Complete/Incomplete Prescription, cost and availability in hospital formulary. Diagnosis with co-morbid condition.Timepoint: At the end of 2 years data will be analyzed

Secondary

MeasureTime frame
Physicians adherence to the guidelines.Timepoint: At the end of 2 years data will be analyzed

Countries

India

Contacts

Public ContactDr Vishal Singh

Tata Memorial Hospital

naveensalins@gmail.com9969683669

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026